focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.50
Bid: 1,812.50
Ask: 1,813.00
Change: 2.50 (0.14%)
Spread: 0.50 (0.028%)
Open: 1,811.00
High: 1,820.00
Low: 1,803.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Macquarie Raises Banks, HSBC Lowers Grocers

Wed, 06th Jul 2016 08:32

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
BARCLAYS RAISES CENTRICA PRICE TARGET TO 240 (230) PENCE - 'EQUAL WEIGHT'
----------
HSBC RAISES SSE SCOTTISH & SOUTHERN PRICE TARGET TO 1660 (1600) PENCE - 'HOLD'
----------
BARCLAYS CUTS EASYJET PRICE TARGET TO 1150 (1630) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS IAG PRICE TARGET TO 420 (700) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES ARM HOLDINGS PRICE TARGET TO 1300 (1250) PENCE - 'OVERWEIGHT'
----------
Liberum Ups Shire Target To 5,500p From 4,700p, Keeps Buy
----------
SOCGEN CUTS MARKS & SPENCER PRICE TARGET TO 307 (424) PENCE - 'HOLD'
----------
HSBC CUTS SAINSBURY(J) PRICE TARGET TO 165 (175) PENCE - 'REDUCE'
----------
HSBC CUTS MORRISON SUPERMARKETS TO 'REDUCE' ('HOLD') - TARGET 135 (165) PENCE
----------
HSBC CUTS TESCO TO 'HOLD' ('BUY') - TARGET 195 (240) PENCE
----------
TRADERS: HSBC REMOVES TESCO FROM 'EUROPE SUPER TEN LIST'
----------
TRADERS: HSBC ADDS GLAXOSMITHKLINE TO 'EUROPE SUPER TEN LIST'
----------
UBS RAISES BURBERRY GROUP PRICE TARGET TO 1700 (1550) PENCE - 'BUY'
----------
BERENBERG RAISES RELX PRICE TARGET TO 1425 (1400) PENCE - 'BUY'
----------
BERENBERG RAISES INFORMA PRICE TARGET TO 750 (725) PENCE - 'HOLD'
----------
MACQUARIE RAISES LLOYDS TO 'OUTPERFORM' (NEUTRAL) - PRICE TARGET 65 (70) PENCE
----------
MACQUARIE CUTS BARCLAYS PRICE TARGET TO 175 (230) PENCE - 'OUTPERFORM'
----------
MACQUARIE RAISES RBS TO 'OUTPERFORM' ('NEUTRAL') - TARGET 200 (220) PENCE
----------
FTSE 250
----------
TRADERS: NUMIS RAISES FIDESSA GROUP TO 'BUY' ('ADD')
----------
HSBC INITIATES TULLETT PREBON WITH 'BUY' - TARGET 380 PENCE
----------
Numis Cuts PageGroup To Add From Buy, Target To 320p From 530p
----------
Numis Cuts Hays To Add From Buy, Target To 110p From 155p
----------
BARCLAYS CUTS WIZZ AIR PRICE TARGET TO 1840 (2200) PENCE - 'OVERWEIGHT'
----------
TRADERS: JPMORGAN RESUMES VECTURA GROUP WITH 'OVERWEIGHT' - TARGET 230 PENCE
----------
TRADERS: DEUTSCHE BANK INITIATES TALK TALK TELECOM WITH 'BUY' - TARGET 300 P
----------
TRADERS: DEUTSCHE BANK RAISES VEDANTA RESOURCES TO 'BUY' ('HOLD')
----------
HSBC CUTS PAGEGROUP TO 'HOLD' ('BUY') - TARGET 320 (510) PENCE
----------
HSBC CUTS HAYS TO 'HOLD' ('BUY') - TARGET 110 (155) PENCE
----------
HSBC RAISES FIRSTGROUP PRICE TARGET TO 105 (100) PENCE - 'HOLD'
----------
HSBC RAISES STAGECOACH GROUP PLC TO 'HOLD' ('REDUCE') - TARGET 235 PENCE
----------
HSBC CUTS ELECTROCOMPONENTS TO 'HOLD' ('BUY') - TARGET 240 (290) PENCE
----------
TRADERS: HSBC CUTS GREAT PORTLAND TO 'HOLD' ('BUY')
----------
TRADERS: HSBC RAISES CAPITAL & COUNTIES TO 'HOLD' ('REDUCE')
----------
BERENBERG RAISES UBM PLC PRICE TARGET TO 640 (610) PENCE - 'HOLD'
----------
TRADERS: GOLDMAN CUTS WEIR GROUP TO 'BUY' ('CONVICTION BUY LIST')
----------
MAIN MARKET AND AIM
----------
SHORE CAPITAL RESUMES SAVANNAH PETROLEUM WITH 'BUY'
----------
Numis Cuts SThree Target To 280p From 330p, Keeps Hold
----------
HSBC CUTS STHREE TO 'HOLD' ('BUY') - TARGET 270 (405) PENCE
----------
Numis Cuts Robert Walters To Hold From Buy, Target To 275p From 445p
----------
BARCLAYS CUTS GULF MARINE PRICE TARGET TO 57 (95) PENCE - 'EQUAL WEIGHT'
----------
Cantor Ups Good Energy Group Target To 250p From 230p, Keeps Buy
----------
LIBERUM RAISES MJ GLEESON PRICE TARGET TO 526 (520) PENCE - 'BUY'
----------
Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.